B of A Securities Maintains Buy on Insulet, Lowers Price Target to $208

Benzinga Newsdesk www.benzinga.com Negative 72.2%

Neg 72.2% Neu 0% Pos 0%

B of A Securities analyst Travis Steed maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $288 to $208.